Optopharm Ltd in Leicester, LE3 9SH

Description

Data updated on: 01-11-2023

The exact moment the company was registered is 19th December 2006. Registered under no. 06032764, the firm is considered a Private Limited Company. You can reach the headquarters of this firm during office times at the following location: 23 Billesdon Close Bradgate Heights, The Grange, LE3 9SH Leicester. This business's Standard Industrial Classification Code is 86900 and has the NACE code: Other human health activities. 2022-03-31 is the last time the accounts were filed.

Nashreen Y. and Umarfarouq J. are the enterprise's directors and have been expanding the company for four years. To help the directors in their tasks, this particular company has been utilizing the skills of Nashreen Y. as a secretary since the appointment on 20th December 2006.

Executives who control the firm include: Nashreen Y. owns 1/2 or less of company shares and has 1/2 or less of voting rights. Umarfarouq J. owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2013-03-31	2014-03-31	2015-03-31	2016-03-31	2017-03-31	2018-03-31	2019-03-31	2020-03-31	2021-03-31	2022-03-31	2023-03-31
Currency
Net Worth	101 275	138 496	110 168	83 447	76 450

Balance Sheet
Cash Bank In Hand	34 799	63 323	16 837	38 257	11 777
Current Assets	48 598	74 710	44 551	70 145	42 421	100 983	101 264	106 743	91 248	65 601	70 519
Debtors	8 080	5 392	14 742	20 820	21 476
Net Assets Liabilities Including Pension Asset Liability	101 275	138 496	110 168	83 447	76 450
Stocks Inventory	5 719	5 995	12 972	11 068	9 168
Tangible Fixed Assets	189 105	215 891	200 828	187 978	182 454
Net Assets Liabilities						82 367	83 654	64 610	51 121	51 195	44 851

Capital & Reserves
Called Up Share Capital	100	100	100	100	100
Profit Loss Account Reserve	101 175	138 396	110 068	83 347	76 350
Shareholder Funds	101 275	138 496	110 168	83 447	76 450

Other Financial Data
Creditors Due After One Year	99 199	114 084	105 544	96 311	102 784
Creditors Due Within One Year	37 229	38 021	29 667	71 510	45 641
Net Current Assets Liabilities	11 369	36 689	14 884	-1 365	-3 220	18 008	18 952	34 533	50 970	27 660	19 101
Number Shares Allotted		100	100	100	100
Par Value Share		1	1	1	1
Secured Debts	106 423	103 418	100 266
Share Capital Allotted Called Up Paid	100	100	100	100	100
Tangible Fixed Assets Additions		41 759	1 800	1 375
Tangible Fixed Assets Cost Or Valuation	206 472	248 231	250 031	251 406	251 406
Tangible Fixed Assets Depreciation	17 367	32 340	49 203	63 428	68 952
Tangible Fixed Assets Depreciation Charged In Period		14 973	16 863	14 225	5 524
Total Assets Less Current Liabilities	200 474	252 580	215 712	186 613	179 234	170 583	166 460	145 645	128 643	158 184	138 866
Average Number Employees During Period								9	9	8	8
Creditors						118 991	120 216	141 276	142 218	93 261	89 620
Fixed Assets			200 828	187 978	182 454	188 591	185 412	180 178	179 613	185 844	157 967
Provisions For Liabilities Balance Sheet Subtotal						5 529	4 187	4 617	4 274	6 822	4 063
Current Asset Investments			16 837	38 257
Provisions For Liabilities Charges				6 855

Company staff

Nashreen Y.

Role: Director

Appointed: 15 September 2020

Latest update: 6 February 2024

Umarfarouq J.

Role: Director

Appointed: 20 December 2006

Latest update: 6 February 2024

Nashreen Y.

Role: Secretary

Appointed: 20 December 2006

Latest update: 6 February 2024

People with significant control

Nashreen Y.

Notified on 19 December 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Umarfarouq J.

Notified on 19 December 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

1/2 or less of shares

Accounts Documents

Account next due date	31 December 2023
Account last made up date	31 March 2022
Confirmation statement next due date	02 January 2024
Confirmation statement last made up date	19 December 2022

Annual Accounts 22 December 2014
Start Date For Period Covered By Report	01 April 2013
End Date For Period Covered By Report	31 March 2014
Date Approval Accounts	22 December 2014
Annual Accounts 26 November 2015
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015
Date Approval Accounts	26 November 2015
Annual Accounts 26 January 2017
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015
Date Approval Accounts	26 January 2017
Annual Accounts 31 December 2017
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015
Date Approval Accounts	31 December 2017
Annual Accounts
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015
Annual Accounts
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015
Annual Accounts
Start Date For Period Covered By Report	01 April 2014
End Date For Period Covered By Report	31 March 2015

Optopharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Nashreen Y.

Umarfarouq J.

Nashreen Y.

People with significant control

Nashreen Y.

Umarfarouq J.

Accounts Documents

Company filings

Filing category

Additional Information

Accountant/Auditor,
2014 - 2015

Name:

Address:

Post code:

City / Town:

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies

Optopharm Ltd

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Nashreen Y.

Umarfarouq J.

Nashreen Y.

People with significant control

Nashreen Y.

Umarfarouq J.

Accounts Documents

Company filings

Filing category

Additional Information

Accountant/Auditor, 2014 - 2015

Name:

Address:

Post code:

City / Town:

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies

Accountant/Auditor,
2014 - 2015